- Home
- DNN vs NVAX Comparison
DNN vs NVAX Comparison
Compare DNN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- NVAX
- Stock Information
- Founded
- DNN 1936
- NVAX 1987
- Country
- DNN Canada
- NVAX United States
- Employees
- DNN N/A
- NVAX N/A
- Industry
- DNN Other Metals and Minerals
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DNN Basic Materials
- NVAX Health Care
- Exchange
- DNN Nasdaq
- NVAX Nasdaq
- Market Cap
- DNN 1.3B
- NVAX 1.3B
- IPO Year
- DNN 1997
- NVAX 1995
- Fundamental
- Price
- DNN $1.80
- NVAX $6.38
- Analyst Decision
- DNN Strong Buy
- NVAX Buy
- Analyst Count
- DNN 2
- NVAX 5
- Target Price
- DNN $3.00
- NVAX $16.60
- AVG Volume (30 Days)
- DNN 185.3M
- NVAX 5.7M
- Earning Date
- DNN 08-07-2025
- NVAX 08-07-2025
- Dividend Yield
- DNN N/A
- NVAX N/A
- EPS Growth
- DNN N/A
- NVAX N/A
- EPS
- DNN N/A
- NVAX 2.97
- Revenue
- DNN $3,176,679.00
- NVAX $1,254,962,000.00
- Revenue This Year
- DNN $288.69
- NVAX $56.85
- Revenue Next Year
- DNN $22.40
- NVAX N/A
- P/E Ratio
- DNN N/A
- NVAX $2.14
- Revenue Growth
- DNN 24.45
- NVAX 25.92
- 52 Week Low
- DNN $1.08
- NVAX $5.01
- 52 Week High
- DNN $2.47
- NVAX $17.81
- Technical
- Relative Strength Index (RSI)
- DNN 60.37
- NVAX 44.45
- Support Level
- DNN $1.72
- NVAX $6.26
- Resistance Level
- DNN $1.83
- NVAX $6.66
- Average True Range (ATR)
- DNN 0.10
- NVAX 0.33
- MACD
- DNN 0.00
- NVAX -0.08
- Stochastic Oscillator
- DNN 79.41
- NVAX 22.16
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.